← FDA Drug Approvals (Drugs@FDA)

ASTEPRO

NDA · New Drug Application · Sponsor: MEDA PHARMS · Approved 2009-08-31

Drug application

FDA Application #

NDA022371

Application type

New Drug Application

Brand name

ASTEPRO

Generic name

Azelastine Hydrochrloride

Active ingredients

AZELASTINE HYDROCHRLORIDE

Dosage form

SPRAY, METERED

Route

NASAL

Marketing status

Prescription

Sponsor

MEDA PHARMS

First approval

2009-08-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown